Trademark Search in Canada

NOVOCOL PHARMA & DESIGN

View On IC.GC.CA

REGISTERED

on 19 Apr 2024

Last Applicant/ Owned by

SEPTODONT HOLDING SAS

58, rue du Pont de CreteilCedex 94107Saint-Maur-des fosses,

Serial Number

1992234 filed on 24^th Oct 2019

Registration Number

TMA1229716 registered on 19^th Apr 2024

Registration expiry Date

19^th Apr 2034

Correspondent Address

METHOD LAW PROFESSIONAL CORPORATION

4211 Yonge StreetSuite 310Toronto

ONTARIO

M2P2A9

NOVOCOL PHARMA & DESIGN

Trademark usage description

pharmaceutical products namely, acne medication, allergy medication, antacids,anthelmintics, antiarrhythmics, antibiotic creams and ointments, antibio Read More

Vienna Information

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 4

BlueBleu

Classification Information

Class [005]
Pharmaceutical products namely, acne medication, allergy medication, antacids,anthelmintics, antiarrhythmics, antibiotic creams and ointments, antibiotics,anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants,antihistamines, antihypertensives anti-infectives, antiinflammatories, antiparasites,antivirals, burn relief medication, calcium channel blockers, central nervous system depressants, central nervous system stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives, pain relief medication,and topical and injectable pharmaceutical products for dental, endodontic and periodontal disorders; anti-epileptic pharmaceutical preparations; bismuth preparations for pharmaceutical use; bromine for pharmaceutical purposes; cardiovascular pharmaceutical preparations; frostbite salve for pharmaceutical purposes; guaiacol for pharmaceutical purposes; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; inhaled pharmaceutical preparations for thetreatment of respiratory diseases and disorders; injectable pharmaceutical contraceptives; pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular orintraocular surgery; pharmaceutical preparations for reducing cholesterol;pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cardiovascular diseases;pharmaceutical preparations for the treatment of carpal tunnel syndrome;pharmaceutical preparations for the treatment of chronic pain; pharmaceuticalpreparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis;pharmaceutical preparations for the treatment of dental and oral diseases;pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cordsystems and related cartilage and tissue; pharmaceutical preparations for the treatmentof drug and alcohol abuse; pharmaceutical preparations for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for thetreatment of genitourinary diseases, namely, urological diseases, infertility, sexuallytransmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for thetreatment of glaucoma; pharmaceutical preparations for the treatment of headaches;pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for thetreatment of immunologic diseases, namely, autoimmune diseases, immunologicdeficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparationsfor the treatment of metabolic diseases and disorders, namely gout, osteoarthritis,muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely bulimia nervosa, anorexia, and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of myalgia and neuralgia;pharmaceutical preparations for the treatment of neurological diseases, namely,Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiplesclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparationsfor the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of physical and psychological addictions, namely,gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders,schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment ofpsychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders,schizophrenia; pharmaceutical preparations for the treatment of respiratory diseases,disorders and infections; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for thetreatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system,namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infectionsof the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal system,namely, connective tissue diseases, bone diseases, spinal diseases, back pain,fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of varicose veins;pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for use in dermatology,namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases;pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for wounds;pharmaceutical products and preparations against dry skin caused by pregnancy;pharmaceutical products and preparations for hydrating the skin during pregnancy;pharmaceutical products for ophthalmological use; pharmaceutical products for treating respiratory diseases; pharmaceutical solutions used in dialysis; radioactive pharmaceutical preparations for invivo diagnostic or therapeutic use; sunburn preparations for pharmaceutical purposes;synthetic peptides for pharmaceutical purposes; disinfection systems, namely all purpose disinfectants; none of the foregoing for the treatment of cancer or oncological diseases and disorders.

Classification kind code

Class [010]
Drug delivery systems, namely needles, syringes, nasal spray bottles, patch pumps, and anesthetic delivery apparatus for medical purposes, but not for use in the fields of diabetes and obesity; drug delivery systems, namely oral and nasal inhalation devices, namely inhalers for therapeutic use, and medical apparatus for facilitating the inhalation of pharmaceutical preparations; none of the foregoing for the treatment of cancer or oncological diseases and disorders.

Classification kind code

Class [040]
Contract manufacturing of clinical batches of pharmaceuticals; consulting services relating to pharmaceutical manufacturing of drug substances and drug products for others, and commercial production of drug substances and drug products for others; none of the foregoing for the treatment of cancer oroncological diseases and disorders.

Classification kind code

Class [042]
Consulting services relating to clinical evaluation and testing, stability studies, method development, formal stability testing of the quality of a drug substance and drug product for others; formulation development services, namely the formulation of new dosage forms and the reformulation of existing drug products; none of the foregoing for the treatment of cancer or oncological diseases and disorders.

Classification kind code

Class [045]
Consulting services to assist companies with obtaining regulatory compliance and licenses for pharmaceuticals and medical devices; regulatory compliance consulting services relating to regulatory registration of drug substances and drug products for others, and registration batches and drug products for new drug applications for others; none of the foregoing for the treatment of cancer or oncological diseasesand disorders.

Classification kind code

Mark Details

Serial Number

1992234

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 110 on 21^st Sept 2022	Proposed Opposition
Submitted for opposition 42 on 3^rd Aug 2022	Advertised
Submitted for opposition 26 on 13^th Jun 2022	Approved
Submitted for opposition 27 on 13^th Jun 2022	Approval Notice Sent
Submitted for opposition 15 on 23^rd Nov 2021	Correspondence Created
Submitted for opposition 22 on 25^th Aug 2021	Search Recorded
Submitted for opposition 20 on 25^th Aug 2021	Examiner's First Report
Submitted for opposition 31 on 12^th Nov 2019	Formalized
Submitted for opposition 30 on 24^th Oct 2019	Filed
Submitted for opposition 1 on 24^th Oct 2019	Created